23 de febrero de 1954.Primera inoculación masiva contra el polio con la vacuna Salk #efemérides #febrero #polio #vacunacion #vacuna #salk
23 de febrero de 1954.Primera inoculación masiva contra el polio con la vacuna Salk #efemérides #febrero #polio #vacunacion #vacuna #salk
🧬🦠 Researchers at the #Salk Institute in #California have discovered that our immune cells carry a molecular record of both our genes and our life experiences.
These "epigenetic fingerprints" determine whether your body mounts a mild response or a severe one when facing the exact same #virus as someone else.
👉 https://scitechdaily.com/this-is-why-the-same-virus-hits-people-so-differently/

Polio may finally be defeated in the next 5 years. Will the world recognize what an extraordinary achievement that is?
"In 1954, national testing began on 1 million children, ages 6-9, who became known as the Polio Pioneers. On 4.12.55, the results were announced: the vaccine was safe & effective. In the 2 yrs before the vaccine was widely available, the average # of polio cases in the U.S. was more than 45,000. By 1962, that # had dropped to 910. . . . #Salk never patented the vaccine or earned any $ from his discovery, preferring it be distributed as widely as possible."
The full, evergreen post on polio:
The US #polio epidemic peaked in 1952: 57,000+ cases, 3,145 died and 21,269 were left with paralysis.
Dr. Jonas #Salk developed a polio vaccine in 1955. (At one point in the #1950s survey respondents found him more recognizable in this country than Dwight #Eisenhower.)
Within two decades, domestic transmission of polio was wiped out in the #US.
Polio never reached natural herd immunity, it was eradicated by #vaccines.
cc: @mcnado
#MattLynch, the only #out #gay #men’s #collegebasketball #coach, posts #winning #record in #history-making #season
At #USCSalkehatchie–“#Salk” for short–he’s in charge of the play calls, along with virtually everything else.
#Women #Transgender #LGBTQ #LGBTQIA #HigherEducation #Entertainment #Sports #Basketball #Representation #Culture
Company continues to be focused on addressing perceived barriers to access and refocusing global efforts on the most-pressing barrier to access: underdiagnosis of the disease.Decision builds on a decade of Company investments in collaborative efforts to help countries sustainably scale up access and bring people living with multidrug-resistant tuberculosis (MDR-TB) into treatment.